市場調查報告書
商品編碼
1115297
圖像引導治療系統的全球市場規模、份額和行業趨勢分析報告:2022-2028 年各應用、最終用戶、產品、地區的展望和預測Global Image-guided Therapy Systems Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Product, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,圖像引導治療系統的全球市場規模預計將達到 55 億美元,在預測期內以 5.4% 的複合年增長率增長。
雖然使用圖像引導的特定治療方法正在增加,但這些治療方法不同於使用圖像提高準確性的傳統方法和使用圖像和專用儀器的非切口方法。目前用於治療內臟和組織狀況的技術可以大致分為兩類。用於圖像引導治療的兩種最常用的橫截面數字成像設備是計算機斷層掃描 (CT) 和磁共振成像 (MRI)。此外,手術導航技術、跟蹤工具和集成軟件用於支持這些程序。
IGT(圖像引導療法)製造用於癌症治療的醫療設備。近年來,醫學界關注以局部腫瘤切除為基礎的新型癌症治療方法。治療局部癌症的一種非常有前途的方法是熱消融,它不是消融腫瘤,而是將腫瘤組織內的溫度提高到致命的閾值,當場將其熄滅。理論已經成立。熱消融治療患者耐受性好,住院時間短。 IGT 基於稱為 FUS 或 HIFU 的聚焦超聲創建了一種非侵入性、對患者友好的圖像引導消融設備。
COVID-19 影響分析
持續研究正在擴展研究方法,以確保它包含基本的 COVID-19 問題和充滿希望的未來可能性。一份考慮 COVID-19 對市場影響的新報告提供了見解、分析、預測和預測。由於 COVID-19 在預測期內代表了前所未有的突發公共衛生事件,因此可能會長期影響行業增長。除了擴展我們的研究方法外,我們正在進行的研究確保包括基本的 COVID-19 問題和潛在的未來方向。考慮到 COVID-19 對市場的影響,這項最新研究包括洞察力、分析、預測和預測。
市場增長因素
全球癌症發病率上升
癌症會影響不同種族、性取向和社會經濟地位的人。儘管在癌症預防和治療方面取得了進展,但癌症發病率似乎在上升。癌症是一個通用術語,指的是可以影響身體任何部位的任何疾病。惡性腫瘤和腫瘤是用於描述癌症的替代術語。癌症的特徵是異常細胞的快速發展,擴散到正常範圍之外,侵入身體的其他部位,並最終侵入其他器官。這樣的動作稱為“過渡”。轉移是癌症患者死亡的主要原因。
影像引導治療技術進步
隨著癌症患病率逐年上升,對治療方法的需求也在增加。圖像引導系統廣泛用於復雜疾病的診斷和治療。在這種背景下,圖像引導治療系統的市場正在擴大。癌症治療需要腫瘤科醫生和放射科醫生在進行治療時監測受影響的區域。這就是圖像引導治療系統發揮作用的地方。隨著越來越多的患者尋求早期發現和治療,預計圖像引導治療系統的使用將在未來幾年內增加。此外,技術進步正在推動對圖像引導治療系統的需求。
市場限制
低收入國家影像引導治療的普及率低
圖像引導手術是一種微創、非視覺手術,使用導管、顯微儀器、活檢針、內窺鏡和激光等工具。 MR單元、導航系統和MR兼容設備的安裝成本通常在100萬日元到幾十萬日元左右。與典型手術室類似的額外年度運營成本也將達到數百萬美元。即使每年進行 1,000 次治療,每次治療至少要多花費數千美元。
產品展望
圖像引導治療系統市場按產品細分為計算機斷層掃描 (CT) 掃描儀、超聲診斷設備、磁共振成像設備 (MRI)、內窺鏡、X 射線熒光鏡、正電子發射斷層掃描 (PET),它是分類為單光子發射計算機斷層掃描 (SPECT)。 2021 年,內窺鏡業務在影像引導治療系統市場的收入份額最高。這是由於越來越多地使用機器人輔助內窺鏡手術和設備成本。此外,各種程序的內鏡引導手術的普及正在推動其增長。
應用前景
圖像引導治療系統市場按應用細分為心髒病學、神經外科、骨科、泌尿科、腫瘤科、腸胃科等。 2021 年,胃腸病學部門在影像引導治療系統市場中的收入份額相當可觀。胃腸病學是醫學的一個分支,專注於消化系統的問題。該專業專注於影響胃腸道的疾病,其中包括從口腔到食道的消化道器官。
最終用戶展望
按最終用戶劃分,它分為醫院、門診手術中心、專科診所以及研究和學術機構。 2021 年,門診手術中心部門在影像引導治療系統市場中取得了可觀的收入份額。這是因為這些醫療機構提供的好處包括減少等待時間和顯著節省資金。該細分市場還受到對微創手術和 ASC 住院時間較短的強烈偏好的推動。
區域展望
按地區分析,圖像引導治療系統市場分佈在四個地區:北美、歐洲、亞太地區和 LAMEA。北美地區將在 2021 年的影像引導治療系統市場中佔據最大的收入份額。這是因為市場包括醫療基礎設施的改進、技術突破和先進放射療法的快速接受。由於慢性病增加和人口老齡化,該區域市場正在增長。私營公司在微創介入和手術領域推出的利好措施有望在未來幾年推動市場擴張。
合作是市場參與者採取的主要策略。根據 Cardinal 矩陣中的分析,Medtronic PLC 和 Siemens Healthineers AG (Siemens AG) 是圖像引導治療系統市場的先驅。 Koninklijke Philips N.V.、Olympus Corporation 和 Stryker Corporation 等公司是影像引導治療系統市場的主要創新者。
The Global Image-guided Therapy Systems Market size is expected to reach $5.5 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.
In radiation therapy, frequent imaging is used to guide treatment, position the patient, and compare the imaging to the pre-therapy imaging from the treatment plan. Before or during a treatment fraction, the patient is located in the treatment room in the same position as intended from the reference imaging dataset. Cone beam computed tomography (CBCT) data acquired on the treatment machine and planning-related computed tomography (CT) data comparison is an illustration of IGRT.
In addition, digitally reconstructed radiographs (DRRs) from the planning CT would be matched with planar megavoltage (MV) or kilovolt age (kV) images. The use of any type of medical imaging to plan, carry out, and assess therapeutic interventions and surgical operations is known as image-guided therapy, and it is a key idea in 21st-century medicine. Surgery can be made less invasive and more exact with the aid of image-guided treatment techniques, which can result in shorter hospital stays and fewer repeat procedures.
Even though there are increasingly more specific procedures that use image guidance, these procedures fall into one of two broad categories: older techniques that use imaging to improve their accuracy and more recent techniques that use imaging and specialized instruments to treat conditions of internal organs and tissues without making an incision. The two most often used cross-sectional digital imaging modalities for image-guided therapy are computed tomography (CT) and magnetic resonance imaging (MRI). Additionally, surgical navigation technology, tracking tools, and integration software are used to support these procedures.
IGT (Image Guided Therapy) creates medical tools for the treatment of cancer. The medical world has recently given new cancer therapy methods based on local tumor ablation a lot of attention. A very promising method for treating localized cancer is thermal ablation therapy, which works on the theory that the tumor is not removed, but rather eliminated in place by increasing the temperature within the tumorous tissues to a deadly threshold. Patients tolerate thermal ablation procedures extremely well, and they spend less time in the hospital as a result. IGT creates image-guided ablation devices that are non-invasive, patient-friendly, and based on focused ultrasound in this situation also known as FUS or HIFU.
COVID-19 Impact Analysis
The continuous study expands upon the research approach to ensure the incorporation of fundamental COVID-19 concerns and prospective future possibilities. The new report, which considers the market impact of COVID-19, offers insights, analyses, projections, and forecasts. Over the forecast period, COVID-19 will be likely to influence industry growth in a long-term manner due to its unprecedented public health emergency. In addition to expanding the research approach, continuous study ensures that basic COVID-19 concerns and potential future directions are included. In this updated study, which accounts for COVID-19's market impact, insights, analyses, projections, and forecasts are included.
Market Growth Factors
Increasing Cancer Incidence Rates Worldwide
Cancer affects people of various racial backgrounds, sexual orientations, and socioeconomic standings. Although there have been advancements in both cancer prevention and treatment, the incidence of cancer diagnosis appears to be rising. Cancer is a general term used to describe any illness that can affect any part of the body. Malignant tumors and neoplasms are alternative terms used to describe cancer. One aspect of cancer is the rapid emergence of abnormal cells that spread past their normal boundaries, invade other bodily parts, and eventually invade other organs. The term "metastasis" refers to this action. Widespread metastases are the primary cause of cancer patient death.
Technology Advancement Of The Image-Guided Therapy Systems
The demands therapeutic methods are rising as cancer incidence rises quickly year after year. Image-guided systems are widely employed in both the diagnosis and treatment of complex disorders. These elements set the stage for expansion in the market for image-guided treatment systems. Oncologists and radiologists must view the affected area while treating cancer. Systems for image-guided therapy are useful in this situation. The use of image-guided therapy systems is anticipated to increase in the upcoming years due to early detection and an increase in the number of patients seeking treatment. A further factor driving demand for image-guided therapeutic systems is technological advancement.
Market Restraining Factors
The Poor Uptake Of Image-Guided Therapy In Low-Income Nations
The tools used in image-guided surgical procedures, which are typically minimally invasive procedures with limited or absent direct visibility, include catheters, micro-instruments, biopsy needles, endoscopes, and lasers. Installation costs for the MR unit, navigation system, and MR-compatible devices typically range from million to dollars. The additional annual operating expenses, which are comparable to those of a typical OR, would also be about millions of USD. Each treatment would cost at least an additional thousands of USD per year, even if the MR machine provided 1,000 treatments annually.
Product Outlook
On the basis of product, the Image-guided Therapy Systems Market is divided into Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscopes, X-ray Fluoroscopy, Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT). The endoscopes segment acquired the highest revenue share in the Image-guided Therapy Systems Market in 2021. It is due to the rising use of robot-assisted endoscopic operations and the cost of the equipment. Its growth has also been aided by the widespread use of endoscope-guided surgery for various procedures.
Application Outlook
Based on the Application, the Image-guided Therapy Systems Market is segmented into Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, and Others. The Gastroenterology segment witnessed a substantial revenue share in the Image-guided Therapy Systems Market in 2021. Gastroenterology is the branch of medicine that focuses on digestive system issues. This specialty focuses on illnesses that affect the gastrointestinal tract, which includes the organs from the mouth into the esophagus along the alimentary canal.
End-Use Outlook
By End-use, the Image-guided Therapy Systems Market is classified into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research & Academic Institutions. The Ambulatory Surgical Centers segment recorded a substantial revenue share in the Image-guided Therapy Systems Market in 2021. It is because of the benefits that these healthcare venues provide, including shorter wait times and significant financial savings. The segment is also being driven by a high preference for minimally invasive procedures and shorter hospital stays in ASCs.
Regional Outlook
Region wise, the Image-guided Therapy Systems Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the largest revenue share in the Image-guided Therapy Systems Market in 2021. It is because the market includes improved healthcare infrastructure, technological breakthroughs, and rapid acceptance of sophisticated radiation therapy. The regional market is expanding as a result of the rising number of chronic diseases and the aging population. In the upcoming years, favorable measures launched by private businesses in the realm of minimally invasive interventional and surgical procedures are anticipated to promote market expansion.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC and Siemens Healthineers AG (Siemens AG) are the forerunners in the Image-guided Therapy Systems Market. Companies such as Koninklijke Philips N.V., Olympus Corporation, Stryker Corporation are some of the key innovators in Image-guided Therapy Systems Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Analogic Corporation, General Electric (GE) Co. (GE Healthcare), Brainlab AG, Olympus Corporation, and Stryker Corporation.
Recent Strategies Deployed in Image-guided Therapy Systems Market
Partnerships, Collaborations and Agreements:
Jul-2022: Medtronic came into a partnership with MathWorks, an Israel-based cardiovascular disease-focused medical technology firm. Together the companies aimed to deliver new, creative solutions and technologies from diagnosis to therapy.
Apr-2022: Medtronic joined hands with GE Healthcare, a leading global medical technology. Together, the companies focused on the special requirements and need for maintenance at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Additionally, consumers can find financial solutions, extensive product offerings, and outstanding service.
Aug-2021: Siemens Healthineers came into a partnership with TeamViewer, a foremost global technology enterprise. Together the companies aimed to allow New Remote Scanning Service WeScan for Diagnostic Imaging. Additionally, WeScan is a new service utilizing TeamViewer's connectivity technology, that allows healthcare suppliers to conduct magnetic resonance imaging (MRI) examinations if they don't have a trained radiology team.
Aug-2021: Royal Philips signed an agreement with NICO.LAB, a MedTech stroke care company. Together with the newly developed stroke abilities of Philips Image Guided Therapy System, Azurion the new partnership particularly promotes Philips' dedication to enhance results for people who suffer a stroke. Additionally, Philips is connecting technologies, information, and people within the stroke care course, allowing care teams to work fast and act critical as a key factor in delivering the finest patient therapy.
Jun-2021: GE Healthcare formed a partnership with the American College of Cardiology, a nonprofit medical association. Together, the companies aimed to produce a roadmap for artificial intelligence (AI) for cardiac supervision and create new techniques for enhanced health effects. Additionally, the partnership would produce new AI for cardiac care and digital technology roadmaps to dive the risks associated to atrial fibrillation management and other connected clinical trails.
Feb-2021: Stryker formed a partnership with Brainomix, an Oxford-based company. Together, the companies aimed to portray a transformative resolution for stroke networks across EMEA, allowing more comprehensive usage of stroke imaging AI devices to assist more patients to achieve permit to life-saving cures.
Feb-2021: Olympus came into a partnership with Imbio, a provider of full quantitative analysis and 3D visualization. Together the companies aimed to assess patient suitability for therapy with the Spiration Valve System, an FDA-designated breakthrough instrument to treat extreme emphysema, a condition of chronic obstructive pulmonary disease.
Product Launches and Product Expansions:
Jun-2022: GE Healthcare launched the Allia platform for minimally invasive, image-guided surgery. The new platform is developed through a multi-year alliance with surgeons and interventionists with the supreme aim of improving the consumer experience, enhancing workflow efficiency, and growing adoption of developed image guidance in daily routine.
Mar-2022: Siemens Healthineers unveiled MAGNETOM Free.Star along with NAEOTOM Alpha, special solutions in MRI and CT portfolio. These solutions are driven by artificial intelligence are useful for nations such as India where is a requirement to fill the gap between the need for developed devices and the lack of trained experts supervising the processes.
Feb-2022: Siemens Healthineers introduced Artis icono biplane, an angiography system. The new Artis icono biplane delivers unique qualities for treating and diagnosing coronary heart disease, cardiac arrhythmia, and structural heart disease that streamline clinical workflows and delivers superior image quality at a lower radiation dose
Feb-2021: Royal Philips unveiled ClarifEye Augmented Reality Surgical Navigation, a new image-guided therapy solution. The new device is developed to offer minimally-invasive spine techniques in the hybrid operating room including Philips' Hybrid offering. Moreover, Philips' new solution integrates 2D and 3D visualizations at low X-ray amounts with 3D augmented reality (AR) to provide live intra-operative visual responses to help exactly place pedicle screws during spinal fusion treatment.
Acquisitions and Mergers:
May-2022: Brainlab completed the acquisition of medPhoton, a developer, that makes robotic imaging for image-guided radiation therapy and surgery. With this acquisition, the company aimed to construct on the earlier conquest of Loop-X and significantly influence the fortune of intraoperative imaging. Moreover, to the extent the market situation of Loop-X as a 3D imaging device for surgery so that doctors can achieve key to cutting-edge tools for patient therapy.
Jan-2022: Medtronic completed the acquisition of Affera, a Boston area-based, personally held medical technology firm. This acquisition would expand Medtronic's offering of developed cardiac ablation products and supplements to fulfill physician requirements within an increasing patient population.
Dec-2021: Royal Philips completed the acquisition of Vesper Medical Inc., a US-based medical technology firm. With this acquisition, Vesper Medical would further extend Philips' offering of therapeutic and diagnostic devices with a developed venous stent suite for the therapy of deep venous disorder.
Dec-2021: GE completed the acquisition of BK Medical, a head in advanced surgical visualization. Through this acquisition, GE Healthcare counts the fast-developing and fairly new field of real-time surgical visualization within GE's pre- and post-operative Ultrasound abilities, forming an end-to-end portfolio through the complete continuum of care from diagnosis via treatment and beyond.
May-2021: GE Healthcare took over Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers. Under this acquisition, the company aimed to convey Zionexa's pipeline biomarkers, along with the newly FDA-approved PET imaging agent, Cerianna, which is utilized as an adjunct to biopsy for the identification of estrogen receptor (ER) favorable lesions to assist inform therapy selection for patients with recurrent or metastatic breast cancer.
Jan-2021: Olympus Corporation completed the acquisition of Quest Photonic Devices B.V., a multispectral imaging leader. With this acquisition, Olympus would reinforce its status as a world leader in medical imaging solutions, and provides creative abilities to surgeons, to create the invisible visible.
Aug-2020: Royal Philips took over Intact Vascular, a medical device company. Through this acquisition, Vascular would improve Philips' image-guided treatment offering, integrating Philips' interventional imaging platform and diagnostic and therapeutic devices within Intact Vascular's unique, technical implantable instrument to optimize the therapy of patients with peripheral arterial disease (PAD).
Approvals and Trials:
Jan-2021: Siemens Healthineers received Food and Drug Administration approval for MAGNETOM Free.Max, a new High-V magnetic resonance scanner. The device combines a 0.55 Tesla field power with profound learning technologies and developed image processing. Additionally, the scanner widens the field of MR clinical applications and delivers consumers the ingrained clinical advantages of a mid-field MR scanner.
Market Segments covered in the Report:
By Application
By End-Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures